SCHEMBL18822012

SCHEMBL18822012

CCOC(=O)C1CCCCC(=O)Nc2cc(NC(=O)OC)ccc2-c2c[nH]c1n2

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F11 P03951 20/20 0.49
KLK1 P06870 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18822013 0.87 F11 (0.59) F11KLK1
SCHEMBL18822005 0.85 F11 (0.51) F11KLK1
SCHEMBL615348 0.85 F11 (0.51) F11KLK1
SCHEMBL615347 0.85 F11 (0.51) F11KLK1
SCHEMBL22294405 0.84 F11 (0.51) F11KLK1
SCHEMBL18822354 0.83 F11 (0.63) F11KLK1
SCHEMBL18822372 0.82 F11 (0.55) F11KLK1
SCHEMBL18822531 0.80 F9 (0.42) F11KLK1
SCHEMBL16408921 0.80 F11 (0.53) F11
SCHEMBL16408920 0.80 F11 (0.53) F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017074833-A1 MACROCYCLIC SPIROCARBAMATE DERIVATIVES AS FACTOR XIA INHIBITORS, PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2017-05-04 WO disclosed